SCHEMBL7837111

SCHEMBL7837111

COc1ccccc1CCN1CCN[C@H](Cc2c[nH]c3ccccc23)C1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ THRB P10828 1/20 0.47
▸ IDO1 P14902 1/20 0.47
▸ RIPK1 Q13546 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ RAB9A P51151 1/20 0.45
▸ POLB P06746 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HTR1A P08908 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ HTR7 P34969 1/20 0.44
▸ HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7835254 1.00 SMN1; SMN2 (0.47) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7835251 1.00 SMN1; SMN2 (0.47) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7824631 0.87 MAPT (0.49) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7836691 0.87 MAPT (0.49) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7824624 0.87 MAPT (0.49) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7825118 0.87 TACR1 (0.46) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7824441 0.87 TACR1 (0.46) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7824450 0.87 TACR1 (0.46) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7834446 0.86 SMN1; SMN2 (0.48) SMN1; SMN2MAPTTP53GLACYP3A4
SCHEMBL7837666 0.86 SMN1; SMN2 (0.48) SMN1; SMN2MAPTTP53GLACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815105-B1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS AVENTIS PHARMA INC (US) 2001-10-04 — — EP disclosed
EP-0815105-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1998-01-07 — — EP disclosed
WO-1996028441-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1996-09-19 — — WO disclosed
Send feedback